EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

New techniques to identify the tissue of origin for cancer of unknown primary in the era of precision medicine: progress and challenges

Wenyuan Ma iD, Hui Wu, Yiran Chen, Hongxia Xu, Junjie Jiang, Bang Du, Mingyu Wan, Xiaolu Ma, Xiaoyu Chen, Lili Lin, Xinhui Su, Xuanwen Bao und 5 weitere

Briefings in Bioinformatics · 22.01.2024 · 25 (2)

DOI: 10.1093/bib/bbae028 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Briefings in Bioinformatics, online erschienen am 11.02.2024. Verfasst von Wenyuan Ma und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Neoplasms, Unknown Primary, Precision Medicine. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, Clinical Research Fund Project of Zhejiang Medical Association, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite a standardized diagnostic examination, cancer of unknown primary (CUP) is a rare metastatic malignancy with an unidentified tissue of origin (TOO). Patients diagnosed with CUP are typically treated with empiric chemotherapy, although their prognosis is worse than those with metastatic cancer of a known origin. TOO identification of CUP has been employed in precision medicine, and subsequent site-specific therapy is clinically helpful. For example, molecular profiling, including genomic profiling, gene expression profiling, epigenetics and proteins, has facilitated TOO identification. Moreover, machine learning has improved identification accuracy, and non-invasive methods, such as liquid biopsy and image omics, are gaining momentum. However, the heterogeneity in prediction accuracy, sample requirements and technical fundamentals among the various techniques is noteworthy. Accordingly, we systematically reviewed the development and limitations of novel TOO identification methods, compared their pros and cons and assessed their potential clinical usefulness. Our study may help patients shift from empirical to customized care and improve their prognoses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasms, Unknown PrimaryPrecision MedicineHumansGene Expression ProfilingBiomarkers, TumorMachine LearningPrognosisGenomicsLiquid Biopsy

Stichwörter der Autor:innen

cancer of unknown primary (CUP)gene expression profilingimage omicsliquid biopsyprecision medicinetissue of origin (TOO)

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Surgical Oncology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University School of Medicine, Zhejiang University, Haining, China.
  • Department of Gastroenterology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Real Doctor AI Research Centre, School of Medicine, Zhejiang University, Hangzhou 310058, China.
  • Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

ORCID-Profile: Wenyuan Ma, Yifei Shen, Yongfeng Ding

Förderung

  • Natural Science Foundation of Zhejiang Province
  • Clinical Research Fund Project of Zhejiang Medical Association
  • National Natural Science Foundation of China

Zitieren

APA

Ma, W., Wu, H., Chen, Y., Xu, H., Jiang, J., Du, B., Wan, M., Ma, X., Chen, X., Lin, L., Su, X., Bao, X., Shen, Y., Xu, N., Ruan, J., Jiang, H., & Ding, Y. (2024). New techniques to identify the tissue of origin for cancer of unknown primary in the era of precision medicine: progress and challenges. Briefings in Bioinformatics, 25(2). https://doi.org/10.1093/bib/bbae028

Vancouver

Ma W, Wu H, Chen Y, Xu H, Jiang J, Du B, et al. New techniques to identify the tissue of origin for cancer of unknown primary in the era of precision medicine: progress and challenges. Briefings in Bioinformatics. 2024;25(2). doi:10.1093/bib/bbae028

BibTeX
@article{Ma2024,
  author = {Ma, Wenyuan and Wu, Hui and Chen, Yiran and Xu, Hongxia and Jiang, Junjie and Du, Bang and Wan, Mingyu and Ma, Xiaolu and Chen, Xiaoyu and Lin, Lili and Su, Xinhui and Bao, Xuanwen and Shen, Yifei and Xu, Nong and Ruan, Jian and Jiang, Haiping and Ding, Yongfeng},
  title = {New techniques to identify the tissue of origin for cancer of unknown primary in the era of precision medicine: progress and challenges},
  journal = {Briefings in Bioinformatics},
  year = {2024},
  volume = {25},
  number = {2},
  doi = {10.1093/bib/bbae028}
}
Kostenlos starten →